HEMO — Hemogenyx Pharmaceuticals Share News
0.000.00%
Last trade - 00:00Grant of Options and Extension of Warrant Term
Final Results
Brief: Hemogenyx Pharmaceuticals Raises £3 Million To Accelerate Clinical Development
Institutional Fundraise
Tech Transfer Completion and Clinical Trial Update
Holding(s) in Company
Exercise of Warrants and Issue of Equity
Issue of Equity - Correction
Issue of Equity
Holding(s) in Company
Update on Admission of Shares
Issue of Equity
Holding(s) in Company
Brief: Hemogenyx Pharmaceuticals Says DSMB Clears Next Dose Level Of HG-CT-1, Opens Pediatric Recruitment
Half-year Report
Brief: Hemogenyx Pharma Signs LOI To Advance Commercialization Of HG-CT-1 CAR-T Therapy In Estonia
Holding(s) in Company
Invitation to Participate at DCNY Summit
Brief: Made Scientific, Hemogenyx Partner to Advance Hg-Ct-1 CAR-T Therapy for AML